ArticleCancers2021

Plasma-Activated Medium Potentiates the Immunogenicity of Tumor Cell Lysates for Dendritic Cell-Based Cancer Vaccines.

Sergej Tomić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.